*Some Market data delayed by 15 mins.

Vir Biotechnology, Inc. Common Stock

Symbol: VIR (NASDAQ)
5.75 ▲ (0.70%) 0.040

Company Description:
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Key Stats
  • Today's Open: $5.72
  • Today's High: $5.995
  • Today's Low: $5.411
  • Today's Volume: 1.24M
  • Yesterday Close: $5.71
  • Yesterday High: $5.79
  • Yesterday Low: $5.47
  • Yesterday Volume: 1.22M
  • Last Min Volume: 25
  • Last Min High: $5.75
  • Last Min Low: $5.75
  • Last Min VWAP: $5.75
Company Profile
  • Name: Vir Biotechnology, Inc. Common Stock
  • Website: https://www.vir.bio
  • Listed Date: 2019-10-11
  • Location: SAN FRANCISCO, CA
  • Market Status: Active
  • CIK Number: 0001706431
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $793.21M
  • Round Lot: 100
  • Outstanding Shares: 138.92M
  • Asset Type: CS
RECENT FILINGS FOR VIR
Filing Date Filing Type Format
2025-10-01 144 View
2025-09-03 4 View
2025-08-06 10-Q View
2025-08-06 8-K View
2025-08-04 4 View
2025-07-24 8-K View
2025-07-17 4 View
2025-07-17 144 View
2025-07-15 144 View
2025-07-02 4 View
2025-07-01 144 View
2025-06-11 144 View
2025-06-10 144 View
2025-06-09 4 View
2025-06-09 144 View
2025-06-06 4 View
2025-06-02 4 View
2025-06-02 4 View
2025-06-02 4 View
2025-06-02 4 View
Latest News on VIR

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.